Singapore Updates AI in Healthcare Guidelines to Strengthen Safety and Governance

Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) have jointly launched refreshed guidelines on the use of artificial intelligence (AI) in healthcare, aiming to enhance patient safety, regulatory clarity, and responsible innovation. The updated framework provides clearer direction on the development, validation, and deployment of AI-driven medical technologies, ensuring alignment with evolving global standards and growing adoption across clinical settings.

Strengthening Oversight of AI-Driven Healthcare Tools

The revised guidelines emphasize robust risk management, transparency, and lifecycle monitoring of AI systems used in healthcare. Developers and healthcare providers are encouraged to ensure proper validation, data integrity, and continuous performance evaluation. This move reinforces Singapore’s commitment to maintaining high safety standards while supporting the integration of AI into diagnostics, treatment planning, and patient care.

Driving Innovation While Ensuring Regulatory Confidence

By refining its regulatory approach, Singapore aims to position itself as a leading hub for digital health innovation in Asia. The updated framework provides greater certainty for companies developing AI-based medical solutions, encouraging investment and collaboration. At the same time, it ensures that innovation is balanced with accountability, fostering trust among healthcare professionals, patients, and industry stakeholders.